Physician profile
Daniel Stone
NPI 1225357395
$20,107.51
in general payments reported to CMS, 2019-2025
19 companies · $551 in 2025
The $551 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $861 · 2021: $924 · 2022: $2,500 · 2023: $4,075 · 2024: $948 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,225 · Food and Beverage: $2,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,224.81 |
| Food and Beverage | $2,349.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $13,465.17 | 2019-2025 | Desara |
| Coloplast Corp | $2,143.64 | 2019-2023 | Saffron |
| Intuitive Surgical, INC. | $726.71 | 2019-2022 | |
| Valencia Technologies Corporation | $673.41 | 2022 | |
| Astellas Pharma US INC | $507.72 | 2019-2023 | Myrbetriq |
| Boston Scientific Corporation | $449.92 | 2019-2023 | Solyx Sis System |
| Axonics, INC. | $437.87 | 2020-2024 | Bulkamid, Axonics |
| Medtronic, INC. | $419.55 | 2022-2024 | Interstim |
| Abbvie INC. | $393.37 | 2022-2025 | Botox |
| Sumitomo Pharma America, INC. | $214.55 | 2023-2025 | Gemtesa |
| Therapeuticsmd, INC. | $168.10 | 2019-2022 | |
| Urovant Sciences INC | $140.66 | 2021-2022 | |
| Coopersurgical, INC. | $119.17 | 2025 | Onetrac Lx |
| Pfizer INC. | $66.90 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $65.52 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $53.66 | 2021-2022 | |
| Acell, INC. | $23.41 | 2019 | |
| Ethicon US, LLC | $19.55 | 2022 | |
| Inspire Medical Systems, INC. | $18.63 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.